title: Waiting for the Antidote: The Journey of Idarucizumab as a Potential Specific Reversal Agent for Dabigatran (Pradaxa).
authors.affiliation: Author Affiliation: Nurse Researcher, Center for Nursing Excellence, Miami Valley Hospital, Dayton, Ohio.
authors.forename: Patricia Anne
authors.initials: PA
authors.lastname: O'Malley
mesh_terms: D061067:Antibodies, Monoclonal, Humanized; D000925:Anticoagulants / Q000627:therapeutic use; D000931:Antidotes; D000069604:Dabigatran / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D006801:Humans; D009720:Nurse Clinicians; D014193:Trauma Centers
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000925:Anticoagulants; D000931:Antidotes; C000594745:idarucizumab; D000069604:Dabigatran